Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibric Acid and Rosuvastatin in Mixed Dyslipidemia
NCT00300482Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibric acid in mixed dyslipidemia, sponsored by Abbott Laboratories. Started Mar 2006; status: completed.
02
Drugs
fenofibric acid
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT00300482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300482.